Home LiteratureArticle Details
PMID: 6193516 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon.

Williamson BD, Carswell EA, Rubin BY, Prendergast JS, Old LJ

Abstract

Human cell lines of hematopoietic origin were tested for production of tumor necrosis factor (TNF). B-cell lines transformed by Epstein-Barr virus release a factor (referred to as hTNF) that is cytotoxic for mouse L cells sensitive to mouse TNF but not for L cells resistant to mouse TNF. Exposure to 4 beta-phorbol 12 beta-myristate 13 alpha-acetate augmented production of hTNF. hTNF activity was not found in supernatants of cell lines of T-cell, monocytic, or promyelocytic origin. Partially purified hTNF has a molecular weight of approximately 70,000, has no interferon activity, is acid labile, is destroyed by heating at 70 degrees C for 1 hr, induces cross-resistance to mouse TNF in vitro, and causes hemorrhagic necrosis of Meth A mouse sarcoma in the standard in vivo mouse TNF assay. Tests with a panel of 23 human cancer cell lines showed that hTNF is cytotoxic for 7 cell lines, cytostatic for 5, and has no effect on 11. Comparative studies with human alpha, beta, and gamma interferons indicated that sensitivity to hTNF and interferon can be distinguished. Combined treatment with hTNF and alpha or gamma interferon resulted in a synergistic cytotoxic effect.

MeSH Terms
Animals B-Lymphocytes/immunology Cell Division/drug effects Cell Line Cell Survival/drug effects Cell Transformation, Viral Cytotoxicity, Immunologic Glycoproteins/immunology Growth Inhibitors/immunology Herpesvirus 4, Human/immunology Humans Interferon Type I/immunology Interferon-gamma/immunology Interferons/pharmacology Kinetics L Cells/immunology Melanoma/immunology Mice Tumor Necrosis Factor-alpha
Chemicals
Glycoproteins Growth Inhibitors Interferon Type I Tumor Necrosis Factor-alpha Interferon-gamma Interferons
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Williamson B D
Carswell E A
Rubin B Y
Prendergast J S
Old L J
References (22)
22 references, click to expand
  1. Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents.
    Proc Natl Acad Sci U S A. 1980 Oct;77(10):5928-32 PMID: 6160587
  2. Macrophages as a source of tumoricidal activity (tumor-necrotizing factor).
    Infect Immun. 1980 Nov;30(2):523-30 PMID: 7002801
  3. Interferon induced in human leukocytes by mitogens: production, partial purification and characterization.
    Eur J Immunol. 1980 Nov;10(11):877-83 PMID: 6161829
  4. Preliminary characterization of the tumor cell cytotoxin in tumor necrosis serum.
    J Immunol. 1981 Apr;126(4):1279-83 PMID: 7204965
  5. Lymphotoxin: properties, role and mode of action.
    Int J Immunopharmacol. 1981;3(1):1-8 PMID: 7028647
  6. Cytotoxic activity of tumor necrosis factor (TNF) on human cancer cells in vitro.
    Jpn J Exp Med. 1981 Jun;51(3):191-4 PMID: 7300034
  7. Comparative antiproliferative activity in vitro of natural interferons alpha and beta for diploid and transformed human cells.
    Cancer Res. 1982 Dec;42(12):4948-53 PMID: 7139598
  8. An endotoxin-induced serum factor that causes necrosis of tumors.
    Proc Natl Acad Sci U S A. 1975 Sep;72(9):3666-70 PMID: 1103152
  9. Effect of tumour necrosis factor on cultured human melanoma cells.
    Nature. 1975 Dec 25;258(5537):731-2 PMID: 1207755
  10. Partial purification of a serum factor that causes necrosis of tumors.
    Proc Natl Acad Sci U S A. 1976 Feb;73(2):381-5 PMID: 54919
  11. Tumor necrosis factor.
    Clin Bull. 1976;6(3):118-20 PMID: 1000787
  12. Corynebacterium parvum as the priming agent in the production of tumor necrosis factor in the mouse.
    J Natl Cancer Inst. 1977 Nov;59(5):1519-22 PMID: 333124
  13. The human LT system. I. Physical-chemical heterogeneity of LT molecules released by mitogen activated human lymphocytes in vitro.
    Cell Immunol. 1978 Jul;38(2):388-402 PMID: 307989
  14. Tumour-necrosis factor from the rabbit. I. Mode of action, specificity and physicochemical properties.
    Br J Cancer. 1978 Aug;38(2):302-9 PMID: 698046
  15. Tumour-necrosis factor from the rabbit. II. Production by monocytes.
    Br J Cancer. 1978 Aug;38(2):310-5 PMID: 698047
  16. Stimulation of RNA synthesis in L-929 cells by rabbit tumor necrosis factor.
    Proc Soc Exp Biol Med. 1979 Mar;160(3):354-8 PMID: 372951
  17. Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferon.
    Cell Immunol. 1980 Feb;49(2):390-4 PMID: 6986204
  18. Generation and characterization of a lipopolysaccharide-induced and serum-derived cytotoxic factor for tumor cells.
    Infect Immun. 1980 Apr;28(1):204-11 PMID: 7380563
  19. Purification and physico-chemical characterization of rabbit tumor necrosis factor.
    J Immunol. 1980 Oct;125(4):1671-7 PMID: 6997383
  20. Tumour-necrosis factor from the rabbit. IV. Purification and chemical characterization.
    Br J Cancer. 1980 Sep;42(3):416-22 PMID: 7426345
  21. Serological survey of normal humans for natural antibody to cell surface antigens of melanoma.
    Proc Natl Acad Sci U S A. 1980 Jul;77(7):4260-4 PMID: 6933476
  22. Spontaneous production of human interferon.
    Proc Natl Acad Sci U S A. 1980 Oct;77(10):5938-42 PMID: 6160588
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1983-09-00
Pages
5397-401
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC384263
Subset
IM
Grants
NIAID NIH HHS · AI-17920 · United States
NCI NIH HHS · CA-08748 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]